Zanubrutinib,Bendamustine,Rituximab,Venetoclax
Beigene,Roche,Abbvie
['$bgne', 'beigene']
beigene highlights promising data from blood cancer portfolio and pipeline at the european hematology association hybrid congress - health stocks hub $bgne 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2